Yes, PRP is considered a safe fertility treatment because it is derived entirely from the patient's own blood, eliminating the risk of allergic reaction or rejection. The procedure involves a routine blood draw and an ultrasound-guided injection, both performed with appropriate care and comfort measures. Discomfort is generally minimal and brief, and the procedure is completed on an outpatient basis with no significant recovery period required for most patients.

Yes on both counts. PRP injected into the uterine cavity has been shown to improve endometrial thickness in women with a persistently thin lining that has not responded to standard estrogen therapy. A thicker and more receptive endometrium significantly improves the chances of successful embryo implantation. For patients with repeated IVF failures, PRP works to improve uterine receptivity and create a more favorable environment for the embryo, potentially making a meaningful difference to the outcome of subsequent cycles.

The number of sessions required varies depending on the patient's clinical condition and the specific goal of treatment. Some patients benefit from a single session while others may require two or more as part of a structured programme. For ovarian PRP, a stimulation cycle may typically be planned 4 to 6 weeks after the procedure. For uterine PRP, embryo transfer can often be planned within the same cycle once the endometrium has responded adequately. Your specialist at Galwa Care Hospital will advise the optimal timing based on your individual monitoring results.

No, PRP does not guarantee improved fertility outcomes and is not a replacement for IVF or other established fertility treatments. It is an emerging and promising adjunct therapy that works best when used alongside a comprehensive, evidence-informed fertility treatment plan. Results vary between individuals depending on the underlying condition, age, and overall reproductive health. At Galwa Care Hospital, PRP is always recommended as part of a broader personalized treatment strategy rather than as a standalone solution for any fertility diagnosis.